Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 9/20 | 0.55 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.45 |
| ▸ | KDR | P35968 | 1/20 | 0.39 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11615908 | 1.00 | ADRB2 (0.55) | ADRB2PTGS2CYP3A4GPR84KDR | |
| SCHEMBL11737358 | 1.00 | ADRB2 (0.55) | ADRB2PTGS2CYP3A4GPR84KDR | |
| SCHEMBL68950 | 1.00 | ADRB2 (0.55) | ADRB2PTGS2CYP3A4GPR84KDR | |
| SCHEMBL11808633 | 1.00 | ADRB2 (0.55) | ADRB2PTGS2CYP3A4GPR84KDR | |
| SCHEMBL69048 | 0.98 | ADRB2 (0.57) | ADRB2PTGS2CYP3A4GPR84KDR | |
| SCHEMBL5916413 | 0.92 | ADRB2 (0.56) | ADRB2PTGS2CYP3A4GPR84TSHR | |
| SCHEMBL14259760 | 0.86 | ADRB2 (0.47) | ADRB2PTGS2GPR84TSHRHIF1A | |
| SCHEMBL5916418 | 0.84 | ADRB2 (0.46) | ADRB2PTGS2CYP3A4TSHRHIF1A | |
| SCHEMBL27627236 | 0.83 | GPR84 (0.44) | ADRB2GPR84KDRSPHK1 | |
| SCHEMBL31545655 | 0.82 | ADRB2 (0.53) | ADRB2PTGS2CYP3A4GPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2479203-A1 | AROMATIC POLYESTER | Muroran Institute of Technology (JP) | 2012-07-25 | — | — | EP | disclosed |
| US-20120172570-A1 | AROMATIC POLYESTER | NITTA CORPORATION | 2012-07-05 | — | — | US | disclosed |
| US-8129493-B2 | Aromatic polyester | MURORAN INSTITUTE OF TECHNOLOGY (JP) | 2012-03-06 | — | — | US | disclosed |
| US-20110224343-A1 | MODIFIER FOR AROMATIC POLYESTER AND AROMATIC POLYESTER RESIN COMPOSITION COMPRISING THE SAME | MURORAN INSTITUTE OF TECHNOLOGY (JP) | 2011-09-15 | — | — | US | disclosed |
| US-20110092662-A1 | AROMATIC POLYESTER | NITTA CORPORATION (JP) | 2011-04-21 | — | — | US | disclosed |
| US-7759526-B2 | Pharmaceutical compositions comprising cannabidiol derivatives | YISSUM RESEARCH DEVELOPMENT COMPANY (IL) | 2010-07-20 | — | — | US | disclosed |
| EP-1289517-B1 | PHARMACEUTICAL COMPOSITIONS COMPRISING CANNABIDIOL DERIVATIVES | YISSUM RES DEV CO (IL) | 2005-11-16 | — | — | EP | disclosed |
| US-20030166727-A1 | Pharmaceutical compositions comprising cannabidiol derivatives | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 2003-09-04 | — | — | US | disclosed |
| EP-1289517-A2 | PHARMACEUTICAL COMPOSITIONS COMPRISING CANNABIDIOL DERIVATIVES | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 2003-03-12 | — | — | EP | disclosed |
| WO-2001095899-A2 | PHARMACEUTICAL COMPOSITIONS COMPRISING CANNABIDIOL DERIVATIVES | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 2001-12-20 | — | — | WO | disclosed |
| US-4876276-A | ANALGESICS, ANTIEMETICS, AND ANTIGLAUCOMA AGENTS NO CANNABIMIMETIC EFFECTS | YISSUM RESEARCH DEVELOPMENT CO. OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 1989-10-24 | — | — | US | disclosed |
| US-4179517-A | DEVOID OF \"CANNABIS-TYPE\" CENTRAL NERVOUS SYSTEM ACTIVITY | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 1979-12-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030166727-A1 | Pharmaceutical compositions comprising cannabidiol derivatives | CNR2, CNR1, FAAH | ADRB2 764/4885PTGS2 296/4885CYP3A4 617/4885 |
| US-20110224343-A1 | MODIFIER FOR AROMATIC POLYESTER AND AROMATIC POLYESTER RESIN COMPOSITION COMPRISING THE SAME | F12, PHAX, WDR82 | ADRB2 1430/4885PTGS2 2866/4885CYP3A4 2028/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.